DsbA Foldases From Multidrug Resistant Pathogens As Targets For New Antimicrobials
Funder
National Health and Medical Research Council
Funding Amount
$743,401.00
Summary
Bacteria that cause common human infections, such as cystitis and diarrhoea, are now resistant to many antibiotics. If no action is taken, by 2050 antibiotic resistant infections will kill more people each year than cancer. This project aims to address this global public health crisis by characterising promising new bacterial targets and inhibitors designed to disarm multidrug resistant pathogens. Longer term this work could provide new infection therapies that are urgently needed.
Pre-clinical evaluation of snake venom proteins with therapeutic potential. Australia harbors some of the most toxic snakes in the world. Their venoms contain a range of substances that are designed to rapidly immobilize and kill their prey. These include agents that lead to enhanced blood clotting; excess bleeding. We have isolated and characterized a large number of the components involved over the last several years. The aim here is to carry out pre-clinical trials in animal models to test th ....Pre-clinical evaluation of snake venom proteins with therapeutic potential. Australia harbors some of the most toxic snakes in the world. Their venoms contain a range of substances that are designed to rapidly immobilize and kill their prey. These include agents that lead to enhanced blood clotting; excess bleeding. We have isolated and characterized a large number of the components involved over the last several years. The aim here is to carry out pre-clinical trials in animal models to test the efficacy of three proteins as anti-bleeding agents and investigate several other novel components. The ultimate outcome will be the development of novel drugs that will have application in the treatment of human disorders. Read moreRead less
Clean fuels for the future: Scale up and optimisation of microalgal oil production and biodiesel synthesis. The development of renewable carbon-neutral fuels is an urgent challenge facing our society. This project aims to develop an innovative system for biodiesel production from local Australian algae species. If cultivated under the right conditions, microalgae are very efficient near-continuous producers of biodiesel and are likely the only renewable source of fuel that could match our curren ....Clean fuels for the future: Scale up and optimisation of microalgal oil production and biodiesel synthesis. The development of renewable carbon-neutral fuels is an urgent challenge facing our society. This project aims to develop an innovative system for biodiesel production from local Australian algae species. If cultivated under the right conditions, microalgae are very efficient near-continuous producers of biodiesel and are likely the only renewable source of fuel that could match our current and future demand without competing for arable land and food production. Such systems couple the national/community benefits of energy generation, carbon-capture, biodiesel production and the clean-up of wastewater. Successful outcomes from this project will bring this innovative technology closer to commercial reality. Read moreRead less
Second generation biofuels: developing environmentally friendly high-efficiency microalgae for biofuel production. The development of CO2-neutral (biodiesel) and CO2-free (hydrogen) fuels is an urgent challenge facing our society to combat climate change and protect against oil price shocks. Successful outcomes from this project will bring this innovative technology closer to commercial reality. The solar-powered microalgal systems being developed, offer a number of national/community benefits ....Second generation biofuels: developing environmentally friendly high-efficiency microalgae for biofuel production. The development of CO2-neutral (biodiesel) and CO2-free (hydrogen) fuels is an urgent challenge facing our society to combat climate change and protect against oil price shocks. Successful outcomes from this project will bring this innovative technology closer to commercial reality. The solar-powered microalgal systems being developed, offer a number of national/community benefits including
1. A high-efficiency frontier-technology for clean fuel production for the Australian and international market
2. A new process to desalinate water
3. Frontier technology to sequester atmospheric CO2
4. Frontier technologies for wealth generation in drought- or salinity-affected and naturally arid regionsRead moreRead less
Targeted bioengineering and systems biology for solar powered hydrogen production in green algal cells. The development of clean fuels to combat climate change and protect against oil price shocks, is an urgent challenge facing our society. Fuels make up ~67% of the energy market, yet most low-CO2 emissions technologies (e.g. nuclear and clean-coal-technology) target the electricity market. In contrast the Solar Bio-H2 process uses algal photobioreactors to drive solar-powered H2 fuel production ....Targeted bioengineering and systems biology for solar powered hydrogen production in green algal cells. The development of clean fuels to combat climate change and protect against oil price shocks, is an urgent challenge facing our society. Fuels make up ~67% of the energy market, yet most low-CO2 emissions technologies (e.g. nuclear and clean-coal-technology) target the electricity market. In contrast the Solar Bio-H2 process uses algal photobioreactors to drive solar-powered H2 fuel production from water (ultimately sea water, facilitating desalination). This project aims to improve the efficiency of the process towards economical levels. The Solar Bio-H2 process reduces water requirements for biofuel production. Locating bioreactors on non-arable land also eliminates competition between biofuel and food production.Read moreRead less
MOLECULAR BREEDING OF CYTOCHROME P450 ENZYMES. Cytochrome P450s are enzymes that catalyse an impressive array of oxidative transformations. However, there is little available data on how to modify their substrate specificity and generate tailored biocatalysts. We plan to use an emerging technology known as DNA shuffling to create libraries of P450s with varying activities. These will then be screened for enzymes that can catalyse the formation of indigo (a blue dye) and indirubin (a chemother ....MOLECULAR BREEDING OF CYTOCHROME P450 ENZYMES. Cytochrome P450s are enzymes that catalyse an impressive array of oxidative transformations. However, there is little available data on how to modify their substrate specificity and generate tailored biocatalysts. We plan to use an emerging technology known as DNA shuffling to create libraries of P450s with varying activities. These will then be screened for enzymes that can catalyse the formation of indigo (a blue dye) and indirubin (a chemotherapeutic agent). The enzymes that catalyse indigo formation will be useful in the production of coloured transgenic plants and those that produce indirubin will have a role in gene therapy.Read moreRead less
Tailored Biodegradable Polymers for Injection Moulding Applications. This project aims to engineer and scale up production of biodegradable injection molded products with tailored properties, processing and biodegradation. Specifically we will focus on novel materials and processing technologies in tandem with biodegradation understandings to expand the utilization of starch-based polymers. We will then combine fundamental rheological and polymer processing skills with and product development ex ....Tailored Biodegradable Polymers for Injection Moulding Applications. This project aims to engineer and scale up production of biodegradable injection molded products with tailored properties, processing and biodegradation. Specifically we will focus on novel materials and processing technologies in tandem with biodegradation understandings to expand the utilization of starch-based polymers. We will then combine fundamental rheological and polymer processing skills with and product development experience from both universities and the industrial partner (Plantic Technologies) to scale up processing and develop successful biodegradable products. This project will also enable an Australian owned start-up company with a broad shareholder base to generate significant export income through key commercialization.Read moreRead less
The link between environmental stress and disease onset in prawn aquaculture. The federal government has set a target for prawn aquaculture production to increase fourfold by 2010. A major barrier is disease: losses of 20% of production to viral diseases are not uncommon. To be internationally competitive, Australia needs to develop high health production systems. Most prawn stock carry chronic viral infections, but only exhibit disease symptoms following environmental stress. This project will ....The link between environmental stress and disease onset in prawn aquaculture. The federal government has set a target for prawn aquaculture production to increase fourfold by 2010. A major barrier is disease: losses of 20% of production to viral diseases are not uncommon. To be internationally competitive, Australia needs to develop high health production systems. Most prawn stock carry chronic viral infections, but only exhibit disease symptoms following environmental stress. This project will identify environmental stressors that activate viral disease in Penaeus monodon. Outcomes will be incorporated into on-farm managerial regimes to minimize risk of crop loss to disease. Development of biomarkers as indicators of stress related risks may be commercialized.Read moreRead less
Alternative Splicing in the Mouse Transcriptome. Although the human genome completion is cause for excitement we do not have any firm indication of precisely how many protein-coding genes exist in a mammalian genome. We have even less indication of the extent to which these genes generate alternative gene products, through a process termed alternative splicing. The detection and sequencing of these full-length alternative gene products is the focus of this application. This application details t ....Alternative Splicing in the Mouse Transcriptome. Although the human genome completion is cause for excitement we do not have any firm indication of precisely how many protein-coding genes exist in a mammalian genome. We have even less indication of the extent to which these genes generate alternative gene products, through a process termed alternative splicing. The detection and sequencing of these full-length alternative gene products is the focus of this application. This application details the opportunity to participate in the identification of the full transcriptome of the mouse and is part of a collaborative effort with The RIKEN Genome Sciences Center in Japan.Read moreRead less
Integrating Immunity And Genetics In Follicular Lymphoma To Establish A Prognostic Score Fit For The Modern Era
Funder
National Health and Medical Research Council
Funding Amount
$1,377,174.00
Summary
Follicular lymphoma (FL) is divided into early and advanced stages. Early stage FL is frequently cured, but there is no way to identify who will be cured and who won't. By contrast advanced stage FL is incurable. Our unique access to well-annotated clinical trial and population based cohorts allows us to perform a detailed biological comparison of early and advanced FL, to gain a deeper understanding of the impediments to eradicating the disease, and to predict outcome to conventional therapy.